Zika vaccine induces robust immune responses in three phase 1 trials

(Beth Israel Deaconess Medical Center) Healthy adults mounted strong immune responses after receiving an investigational whole inactivated Zika virus vaccine, according to interim analyses of three Phase 1, placebo-controlled, double-blind trials conducted at Beth Israel Deaconess Medical Center (BIDMC), Walter Reed Army Institute of Research (WRAIR), and Saint Louis University School of Medicine. The findings were published today in The Lancet.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news